カテゴリー： QYResearch, 世界

世界のドライアイ症候群薬市場 2019年

【英語タイトル】Global Dry Eye Syndrome Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X06827）・商品コード：DATA909X06827
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ドライアイ症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗生物質ドロップ、ホルモンドロップ、人工涙液、その他に、用途別には、病院、診療所、家庭用、その他にセグメント区分し、ドライアイ症候群薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・ドライアイ症候群薬の世界市場概要
・ドライアイ症候群薬の製造コスト構成分析
・ドライアイ症候群薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ドライアイ症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ドライアイ症候群薬のセグメント分析（種類別）
（抗生物質ドロップ、ホルモンドロップ、人工涙液、その他）
・ドライアイ症候群薬のセグメント分析（用途別）
（病院、診療所、家庭用、その他）
・ドライアイ症候群薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Allergan、Novartis、Santen、Shire、Otsuka、Eyegate Pharma、Can-Fite BioPharma、Bausch & Lomb、）
・ドライアイ症候群薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Dry Eye Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Dry Eye Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dry Eye Syndrome Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dry Eye Syndrome Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dry Eye Syndrome Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan
Novartis
Santen
Shire
Otsuka
Eyegate Pharma
Can-Fite BioPharma
Bausch & Lomb

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Antibiotic Drops
Hormone Drops
Artificial Tears
Others

Segment by Application
Hospitals
Clinics
Household Use
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Dry Eye Syndrome Drugs
1.1 Definition of Dry Eye Syndrome Drugs
1.2 Dry Eye Syndrome Drugs Segment by Type
1.2.1 Global Dry Eye Syndrome Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Antibiotic Drops
1.2.3 Hormone Drops
1.2.4 Artificial Tears
1.2.5 Others
1.3 Dry Eye Syndrome Drugs Segment by Applications
1.3.1 Global Dry Eye Syndrome Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Dry Eye Syndrome Drugs Overall Market
1.4.1 Global Dry Eye Syndrome Drugs Revenue (2014-2025)
1.4.2 Global Dry Eye Syndrome Drugs Production (2014-2025)
1.4.3 North America Dry Eye Syndrome Drugs Status and Prospect (2014-2025)
1.4.4 Europe Dry Eye Syndrome Drugs Status and Prospect (2014-2025)
1.4.5 China Dry Eye Syndrome Drugs Status and Prospect (2014-2025)
1.4.6 Japan Dry Eye Syndrome Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Dry Eye Syndrome Drugs Status and Prospect (2014-2025)
1.4.8 India Dry Eye Syndrome Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Dry Eye Syndrome Drugs
2.3 Manufacturing Process Analysis of Dry Eye Syndrome Drugs
2.4 Industry Chain Structure of Dry Eye Syndrome Drugs

3 Development and Manufacturing Plants Analysis of Dry Eye Syndrome Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Dry Eye Syndrome Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Dry Eye Syndrome Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Dry Eye Syndrome Drugs Production and Capacity Analysis
4.2 Dry Eye Syndrome Drugs Revenue Analysis
4.3 Dry Eye Syndrome Drugs Price Analysis
4.4 Market Concentration Degree

5 Dry Eye Syndrome Drugs Regional Market Analysis
5.1 Dry Eye Syndrome Drugs Production by Regions
5.1.1 Global Dry Eye Syndrome Drugs Production by Regions
5.1.2 Global Dry Eye Syndrome Drugs Revenue by Regions
5.2 Dry Eye Syndrome Drugs Consumption by Regions
5.3 North America Dry Eye Syndrome Drugs Market Analysis
5.3.1 North America Dry Eye Syndrome Drugs Production
5.3.2 North America Dry Eye Syndrome Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Dry Eye Syndrome Drugs Import and Export
5.4 Europe Dry Eye Syndrome Drugs Market Analysis
5.4.1 Europe Dry Eye Syndrome Drugs Production
5.4.2 Europe Dry Eye Syndrome Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Dry Eye Syndrome Drugs Import and Export
5.5 China Dry Eye Syndrome Drugs Market Analysis
5.5.1 China Dry Eye Syndrome Drugs Production
5.5.2 China Dry Eye Syndrome Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Dry Eye Syndrome Drugs Import and Export
5.6 Japan Dry Eye Syndrome Drugs Market Analysis
5.6.1 Japan Dry Eye Syndrome Drugs Production
5.6.2 Japan Dry Eye Syndrome Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Dry Eye Syndrome Drugs Import and Export
5.7 Southeast Asia Dry Eye Syndrome Drugs Market Analysis
5.7.1 Southeast Asia Dry Eye Syndrome Drugs Production
5.7.2 Southeast Asia Dry Eye Syndrome Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Dry Eye Syndrome Drugs Import and Export
5.8 India Dry Eye Syndrome Drugs Market Analysis
5.8.1 India Dry Eye Syndrome Drugs Production
5.8.2 India Dry Eye Syndrome Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Dry Eye Syndrome Drugs Import and Export

6 Dry Eye Syndrome Drugs Segment Market Analysis (by Type)
6.1 Global Dry Eye Syndrome Drugs Production by Type
6.2 Global Dry Eye Syndrome Drugs Revenue by Type
6.3 Dry Eye Syndrome Drugs Price by Type

7 Dry Eye Syndrome Drugs Segment Market Analysis (by Application)
7.1 Global Dry Eye Syndrome Drugs Consumption by Application
7.2 Global Dry Eye Syndrome Drugs Consumption Market Share by Application (2014-2019)

8 Dry Eye Syndrome Drugs Major Manufacturers Analysis
8.1 Allergan
8.1.1 Allergan Dry Eye Syndrome Drugs Production Sites and Area Served
8.1.2 Allergan Product Introduction, Application and Specification
8.1.3 Allergan Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis Dry Eye Syndrome Drugs Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Santen
8.3.1 Santen Dry Eye Syndrome Drugs Production Sites and Area Served
8.3.2 Santen Product Introduction, Application and Specification
8.3.3 Santen Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Shire
8.4.1 Shire Dry Eye Syndrome Drugs Production Sites and Area Served
8.4.2 Shire Product Introduction, Application and Specification
8.4.3 Shire Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Otsuka
8.5.1 Otsuka Dry Eye Syndrome Drugs Production Sites and Area Served
8.5.2 Otsuka Product Introduction, Application and Specification
8.5.3 Otsuka Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eyegate Pharma
8.6.1 Eyegate Pharma Dry Eye Syndrome Drugs Production Sites and Area Served
8.6.2 Eyegate Pharma Product Introduction, Application and Specification
8.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Can-Fite BioPharma
8.7.1 Can-Fite BioPharma Dry Eye Syndrome Drugs Production Sites and Area Served
8.7.2 Can-Fite BioPharma Product Introduction, Application and Specification
8.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bausch & Lomb
8.8.1 Bausch & Lomb Dry Eye Syndrome Drugs Production Sites and Area Served
8.8.2 Bausch & Lomb Product Introduction, Application and Specification
8.8.3 Bausch & Lomb Dry Eye Syndrome Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Dry Eye Syndrome Drugs Market
9.1 Global Dry Eye Syndrome Drugs Market Trend Analysis
9.1.1 Global Dry Eye Syndrome Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Dry Eye Syndrome Drugs Regional Market Trend
9.2.1 North America Dry Eye Syndrome Drugs Forecast 2019-2025
9.2.2 Europe Dry Eye Syndrome Drugs Forecast 2019-2025
9.2.3 China Dry Eye Syndrome Drugs Forecast 2019-2025
9.2.4 Japan Dry Eye Syndrome Drugs Forecast 2019-2025
9.2.5 Southeast Asia Dry Eye Syndrome Drugs Forecast 2019-2025
9.2.6 India Dry Eye Syndrome Drugs Forecast 2019-2025
9.3 Dry Eye Syndrome Drugs Market Trend (Product Type)
9.4 Dry Eye Syndrome Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Dry Eye Syndrome Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Dry Eye Syndrome Drugs
Table Global Dry Eye Syndrome Drugs Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Dry Eye Syndrome Drugs Production Market Share by Types in 2018
Figure Antibiotic Drops Product Picture
Figure Hormone Drops Product Picture
Figure Artificial Tears Product Picture
Figure Others Product Picture
Table Global Dry Eye Syndrome Drugs Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Dry Eye Syndrome Drugs Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Household Use
Figure Others
Figure Global Dry Eye Syndrome Drugs Revenue (Million USD) (2014-2025)
Figure Global Dry Eye Syndrome Drugs Production (K MT) (2014-2025)
Figure North America Dry Eye Syndrome Drugs Market Size (Million USD) (2014-2025)
Figure Europe Dry Eye Syndrome Drugs Market Size (Million USD) (2014-2025)
Figure China Dry Eye Syndrome Drugs Market Size (Million USD) (2014-2025)
Figure Japan Dry Eye Syndrome Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Dry Eye Syndrome Drugs Market Size (Million USD) (2014-2025)
Figure India Dry Eye Syndrome Drugs Market Size (Million USD) (2014-2025)
Table Dry Eye Syndrome Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Dry Eye Syndrome Drugs in 2018
Figure Manufacturing Process Analysis of Dry Eye Syndrome Drugs
Figure Industry Chain Structure of Dry Eye Syndrome Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Dry Eye Syndrome Drugs Manufacturing Plants Distribution
Table Dry Eye Syndrome Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Dry Eye Syndrome Drugs Capacity (K MT) of Major Manufacturers (2014-2019)
Table Dry Eye Syndrome Drugs Production (K MT) of Major Manufacturers (2014-2019)
Table Dry Eye Syndrome Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Dry Eye Syndrome Drugs Production Share by Manufacturers in 2018
Table Dry Eye Syndrome Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Dry Eye Syndrome Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Dry Eye Syndrome Drugs Revenue Share by Manufacturers in 2018
Table Dry Eye Syndrome Drugs Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Dry Eye Syndrome Drugs Production by Regions 2014-2019 (K MT)
Table Global Dry Eye Syndrome Drugs Production Market Share by Regions 2014-2019
Figure Global Dry Eye Syndrome Drugs Production Market Share by Regions in 2018
Table Global Dry Eye Syndrome Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Dry Eye Syndrome Drugs Revenue Market Share by Regions 2014-2019
Figure Global Dry Eye Syndrome Drugs Revenue Market Share by Regions in 2018
Table Global Dry Eye Syndrome Drugs Consumption by Regions 2014-2019 (K MT)
Table Global Dry Eye Syndrome Drugs Consumption Market Share by Regions 2014-2019
Figure North America Dry Eye Syndrome Drugs Production Growth Rate 2014-2019 (K MT)
Figure North America Dry Eye Syndrome Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Dry Eye Syndrome Drugs Production, Consumption Import and Export (K MT)
Figure Europe Dry Eye Syndrome Drugs Production Growth Rate 2014-2019 (K MT)
Figure Europe Dry Eye Syndrome Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Dry Eye Syndrome Drugs Production, Consumption Import and Export (K MT)
Figure China Dry Eye Syndrome Drugs Production Growth Rate 2014-2019 (K MT)
Figure China Dry Eye Syndrome Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Dry Eye Syndrome Drugs Production, Consumption Import and Export (K MT)
Figure Japan Dry Eye Syndrome Drugs Production Growth Rate 2014-2019 (K MT)
Figure Japan Dry Eye Syndrome Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Dry Eye Syndrome Drugs Production, Consumption Import and Export (K MT)
Figure Southeast Asia Dry Eye Syndrome Drugs Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Dry Eye Syndrome Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Dry Eye Syndrome Drugs Production, Consumption Import and Export (K MT)
Figure India Dry Eye Syndrome Drugs Production Growth Rate 2014-2019 (K MT)
Figure India Dry Eye Syndrome Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Dry Eye Syndrome Drugs Production, Consumption Import and Export (K MT)
Figure Global Consumption Dry Eye Syndrome Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Dry Eye Syndrome Drugs Market Share by Application (2014-2019)
Table Allergan Dry Eye Syndrome Drugs Production Sites and Area Served
Table Allergan Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Allergan Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Allergan Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Allergan Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Allergan Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Allergan Dry Eye Syndrome Drugs Main Business and Markets Served
Table Novartis Dry Eye Syndrome Drugs Production Sites and Area Served
Table Novartis Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Novartis Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Novartis Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Novartis Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Novartis Dry Eye Syndrome Drugs Main Business and Markets Served
Table Santen Dry Eye Syndrome Drugs Production Sites and Area Served
Table Santen Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Santen Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Santen Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Santen Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Santen Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Santen Dry Eye Syndrome Drugs Main Business and Markets Served
Table Shire Dry Eye Syndrome Drugs Production Sites and Area Served
Table Shire Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Shire Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Shire Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Shire Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Shire Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Shire Dry Eye Syndrome Drugs Main Business and Markets Served
Table Otsuka Dry Eye Syndrome Drugs Production Sites and Area Served
Table Otsuka Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Otsuka Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Otsuka Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Otsuka Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Otsuka Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Otsuka Dry Eye Syndrome Drugs Main Business and Markets Served
Table Eyegate Pharma Dry Eye Syndrome Drugs Production Sites and Area Served
Table Eyegate Pharma Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Eyegate Pharma Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Eyegate Pharma Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Eyegate Pharma Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Eyegate Pharma Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Eyegate Pharma Dry Eye Syndrome Drugs Main Business and Markets Served
Table Can-Fite BioPharma Dry Eye Syndrome Drugs Production Sites and Area Served
Table Can-Fite BioPharma Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Can-Fite BioPharma Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Can-Fite BioPharma Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Can-Fite BioPharma Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Can-Fite BioPharma Dry Eye Syndrome Drugs Main Business and Markets Served
Table Bausch & Lomb Dry Eye Syndrome Drugs Production Sites and Area Served
Table Bausch & Lomb Dry Eye Syndrome Drugs Product Introduction, Application and Specification
Table Bausch & Lomb Dry Eye Syndrome Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bausch & Lomb Dry Eye Syndrome Drugs Production Growth Rate (2014-2019)
Table Bausch & Lomb Dry Eye Syndrome Drugs Production Market Share (2014-2019)
Figure Bausch & Lomb Dry Eye Syndrome Drugs Revenue Market Share (2014-2019)
Table Bausch & Lomb Dry Eye Syndrome Drugs Main Business and Markets Served
Figure Global Dry Eye Syndrome Drugs Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Dry Eye Syndrome Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Dry Eye Syndrome Drugs Sales Price (USD/MT) Forecast 2019-2025
Figure North America Dry Eye Syndrome Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Dry Eye Syndrome Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Dry Eye Syndrome Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Dry Eye Syndrome Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Dry Eye Syndrome Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Dry Eye Syndrome Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Dry Eye Syndrome Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Dry Eye Syndrome Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Dry Eye Syndrome Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Dry Eye Syndrome Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Dry Eye Syndrome Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Dry Eye Syndrome Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Dry Eye Syndrome Drugs by Type (2019-2025)
Table Global Consumption (K MT) of Dry Eye Syndrome Drugs by Application (2019-2025)
Table Dry Eye Syndrome Drugs Distributors List
Table Dry Eye Syndrome Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Allergan、Novartis、Santen、Shire、Otsuka、Eyegate Pharma、Can-Fite BioPharma、Bausch & Lomb、

★調査レポート[世界のドライアイ症候群薬市場 2019年] (コード：DATA909X06827)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のドライアイ症候群薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のギランバレー症候群薬市場 2019年
    DATA909X08653 / QYResearch / 2019年11月15日 / ※本調査レポートは、ギランバレー症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Coversin、免疫グロブリン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ギランバレー症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ギランバレー症候群薬の世界市場概要 ・ギランバレー症候群薬の製造コスト構成分析 ・ギランバレー症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ギランバレー症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ギランバレー症候群薬のセグメント分析（種類別） （Coversin、免疫グロブリン、その他）...The global Guillain-Barre Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Guillain-Barre Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Guillain-Barre Syndrome Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Guillain-Barre Syndrome Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の便秘薬による過敏性腸症候群市場 2019年
    DATA909X10087 / QYResearch / 2019年11月20日 / ※本調査レポートは、便秘薬による過敏性腸症候群の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、便秘薬による過敏性腸症候群の世界市場を分析しました。 ・エグゼクティブ・サマリー ・便秘薬による過敏性腸症候群の世界市場概要 ・便秘薬による過敏性腸症候群の製造コスト構成分析 ・便秘薬による過敏性腸症候群の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・便秘薬による過敏性腸症候群の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・便秘薬による過敏性腸症候群のセグメント分析（種類別） （ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他）...The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Constipation Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Constipation Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Constipation Drugs in North America, Europe, China,...
  • 世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場 2019年
    DATA909X10088 / QYResearch / 2019年11月20日 / ※本調査レポートは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミンに、用途別には、病院、診療所、その他にセグメント区分し、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要 ・下痢を伴う過敏性腸症候群（IBS-D）薬の製造コスト構成分析 ・下痢を伴う過敏性腸症候群（IBS-D）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・下痢を伴う過敏性腸症候群（IBS-D）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・下痢を伴う過敏性腸症候群（IBS-D）薬のセグメント分析（種類別） （序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミン）...The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のアッシャー症候群治療法市場 2019年
    DATA909X17192 / QYResearch / 2019年11月22日 / ※本調査レポートは、アッシャー症候群治療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、NT-501、QRX-411、QRX-421、SAR-421869、その他に、用途別には、クリニック、病院、その他にセグメント区分し、アッシャー症候群治療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・アッシャー症候群治療法の世界市場概要 ・アッシャー症候群治療法の製造コスト構成分析 ・アッシャー症候群治療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・アッシャー症候群治療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・アッシャー症候群治療法のセグメント分析（種類別） （NT-501、QRX-411、QRX-421、SAR-421869、その他）...The global Usher Syndrome Threapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Usher Syndrome Threapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Usher Syndrome Threapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Usher Syndrome Threapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の骨髄異形成症候群（MDS）治療薬市場 2019年
    DATA909X11785 / QYResearch / 2019年11月20日 / ※本調査レポートは、骨髄異形成症候群（MDS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他に、用途別には、入院患者、外来患者にセグメント区分し、骨髄異形成症候群（MDS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・骨髄異形成症候群（MDS）治療薬の世界市場概要 ・骨髄異形成症候群（MDS）治療薬の製造コスト構成分析 ・骨髄異形成症候群（MDS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・骨髄異形成症候群（MDS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・骨髄異形成症候群（MDS）治療薬のセグメント分析（種類別） （アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）...The global Myelodysplastic Syndrome (MDS) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myelodysplastic Syndrome (MDS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myelodysplastic Syndrome (MDS) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myelodysplastic Syndrome (MDS) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のトゥレット症候群薬市場 2019年
    DATA909X16695 / QYResearch / 2019年11月22日 / ※本調査レポートは、トゥレット症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他に、用途別には、研究センター、病院、クリニック、その他にセグメント区分し、トゥレット症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・トゥレット症候群薬の世界市場概要 ・トゥレット症候群薬の製造コスト構成分析 ・トゥレット症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・トゥレット症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・トゥレット症候群薬のセグメント分析（種類別） （AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他）...The global Tourette Syndrome Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tourette Syndrome Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tourette Syndrome Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tourette Syndrome Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆